Coronavirus infection (Covid – 19) in children with cystic fibrosis in the Russian Federation

E. Zhekaite (Moscow, Russian Federation), E. Kondratyeva (Moscow, Russian Federation), V. Sherman (Moscow, Russian Federation), O. Simonova (Moscow, Russian Federation), Y. Gorinova (Moscow, Russian Federation), A. Voronkova (Moscow, Russian Federation)

Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Session: Epidemiology and burden of tuberculosis and other lung diseases
Session type: E-poster
Number: 1732

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Zhekaite (Moscow, Russian Federation), E. Kondratyeva (Moscow, Russian Federation), V. Sherman (Moscow, Russian Federation), O. Simonova (Moscow, Russian Federation), Y. Gorinova (Moscow, Russian Federation), A. Voronkova (Moscow, Russian Federation). Coronavirus infection (Covid – 19) in children with cystic fibrosis in the Russian Federation. 1732

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Rhinovirus infections in the upper and lower airways of young Australian children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Clinical features of adult’s cystic fibrosis in the Republic of Belarus
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Evidence incidence of cystic fibrosis: A 30-year study in Krasnoyarsk, Russia
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013

Audit of management of pseudomonas aeruginosa infection in children with cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009


Paediatrics in Barcelona: highlights from the 2010 ERS Annual Congress
Source: Eur Respir J 2011; 37: 1514-1521
Year: 2011



Differential interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Audit on the MRSA infection in adults with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004

Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011


Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
Source: Eur Respir J, 57 (4) 2100048; 10.1183/13993003.00048-2021
Year: 2021



Hypomagnesaemia in patients with cystic fibrosis (CF) in R. Macedonia
Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects
Year: 2008

Paediatrics in Amsterdam
Source: Eur Respir J 2012; 40: 215-226
Year: 2012



p.Leu206Trp mutation: Genotype-phenotype correlation in 23 paediatric / adults cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Tuberculosis among children with cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012


Anaerobic and aerobic bacterial load of childhood non- cystic fibrosis bronchiectasis
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014

Lung function of idiopathic pulmonary fibrosis: Russian IPF registry (Moscow region)
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019


Non- cystic fibrosis bronchiectasis in primary antibody deficiency patients
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014


Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015


Tuberculosis treatment outcomes in HIV co-infected patients in Novokuznetsk, Russian Federation
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Respiratory viruses in healthy infants and infants with cystic fibrosis. A prospective cohort study
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016

Paediatrics in Vienna
Source: Eur Respir J 2010; 35: 1172-1179
Year: 2010